Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”

Overview of attention for article published in International Journal of Nephrology and Renovascular Disease, July 2011

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 public wall posts from 2 users.

By ICIM Speaker Marty Hinz MD: Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter…

When a treatment provider wants to test your neurotransmitter levels by urine and then either sell you supplements or direct…